“ОШ КЛИНИКАСЫ” МЕДИЦИНАЛЫК БОРБОРУНУН МИСАЛЫНДА АРТЕРИЯЛЫК ГИПЕРТЕНЗИЯНЫ ДАРЫЛООДО ТИАЗИДДИК ЖАНА ТИАЗИД СЫМАЛ ДИУРЕТИКТЕРДИН САЛЫШТЫРМАЛУУ НАТЫЙЖАЛУУЛУГУ
DOI:
https://doi.org/10.52754/16948610_2024_2_6Ачкыч сөздөр:
thiazide and thiazide-like diuretics, indap, hydrochlorothiazide, hypertensionАннотация
Бул иште "Ош"клиникасында бейтаптардын айрым топторунда артериялык гипертензия терапиясында тиазиддик (гидрохлоротиазид) жана тиазид сымал (индап) диуретиктерди колдонуунун салыштырмалуу натыйжалуулугу каралат. Гидрохлортиазидге салыштырмалуу индаптын гипертензияга каршы узак мөөнөттүү таасири, кандагы липиддердин жана углеводдордун деңгээлине минималдуу таасири жана нефропротектордук касиети бар экени аныкталды.
Библиографиялык шилтемелер
Tamargo J., Segura J., Ruilope L.M. Diuretics in the treatment of hypertension. Part 1: thiazide and thi¬azide-like diuretics. Expert Opin Pharmacother. 2014;15(4):527-47. DOI:10.1517/14656566. 2014.879118. DOI: https://doi.org/10.1517/14656566.2014.879118
Williams B., Mancia G., Spiering W., et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-3104. DOI:10.1093/eurheartj/ehy339. DOI: https://doi.org/10.1093/eurheartj/ehy439
Rubricator of clinical guidelines of the Ministry of Health of the Russian Federation: clinical guidelines "Arterial hypertension in adults" [cited by Nov 23, 2020]. Available from: http://cr.rosminzdrav.ru/recomend/687 (In Russ.).
Thomopoulos C., Parati G., Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials. J Hy¬pertens. 2014;32(12):2285-95. DOI:10.1097/HJH.0000000000000378. DOI: https://doi.org/10.1097/HJH.0000000000000378
Weidmann P. Metabolic profile of indapamide sustained-release in patients with hypertension: data from three randomised double-blind studies. Drug Saf. 2001;24(15):1155-65. DOI:10.2165/00002018-200124150-00006. DOI: https://doi.org/10.2165/00002018-200124150-00006
Marre M., Puig J.G., Kokot F., et al. Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR Study. J Hypertens. 2004;22(8):1613-22. DOI:10.1097/01.hjh.0000133733.32125.09. DOI: https://doi.org/10.1097/01.hjh.0000133733.32125.09
Bahtiyar G., Gutterman D., Lebovitz H. Heart Failure: a Major Cardiovascular Complication of Diabetes Mellitus. Curr Diab Rep. 2016;16(11):116. DOI:10.1007/s11892-016-0809-4. DOI: https://doi.org/10.1007/s11892-016-0809-4
Zhang Y., Agnoletti D., Wang J.G., et al. Natriuresis and blood pressure reduction in hypertensive pa¬tients with diabetes mellitus: the NESTOR study. J Am Soc Hypertens. 2015;9(1):21-8. DOI:10.1016/j.jash.2014.10.003. DOI: https://doi.org/10.1016/j.jash.2014.10.003
Beckett N.S., Peters R., Fletcher A.E., et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18):1887-98. DOI:10.1056/NEJMoa0801369. DOI: https://doi.org/10.1056/NEJMoa0801369
Roush G.C., Abdelfattah R., Song S., et al. Hydrochlorothiazide and alternative diuretics versus renin-angiotensin system inhibitors for the regression of left ventricular hypertrophy: a head-to-head meta-analysis. J Hypertens. 2018;36(6):1247-55. DOI:10.1097/HJH.0000000000001691. DOI: https://doi.org/10.1097/HJH.0000000000001691
Vinereanu D., Dulgheru R., Magda S., et al. The effect of indapamide versus hydrochlorothiazide on ventricular and arterial function in patients with hypertension and diabetes: results of a randomized trial. Am Heart J. 2014;168(4):446-56. DOI:10.1016/j.ahj.2014.06.010. DOI: https://doi.org/10.1016/j.ahj.2014.06.010
Campbell DB. The possible mode of action of indapamide: a review. Current Medical Research and Opinion. 1983;8(Suppl 3):9–24. DOI:10.1185/03007998309109832. DOI: https://doi.org/10.1185/03007998309109832
Pareek AK, Messerli FH, Chandurkar NB, Dharmadhikari SK, Godbole AV, Kshirsagar PP et al. Efficacy of Low-Dose Chlorthalidone and Hydrochlorothiazide as Assessed by 24-h Ambulatory Blood Pressure Monitoring. Journal of the American College of Cardiology. 2016;67(4):379–89. DOI: 10.1016/j.jacc.2015.10.083. DOI: https://doi.org/10.1016/j.jacc.2015.10.083
Tereshchenko S.N., Dzhaiani N.A., Akimov A.E., Gnidkina N.A., Kochetov A.G. Indapamide retard in complex therapy of patients with chronic heart failure and arterial hypertension. Cardiovascular Therapy and Prevention. 2010;9(2):43–7.
Zillich AJ, Garg J, Basu S, Bakris GL, Carter BL. Thiazide Diuretics, Potassium, and the Development of Diabetes: A Quantitative Review. Hypertension. 2006;48(2):219–24. DOI: 10.1161/01. HYP.0000231552.10054. DOI: https://doi.org/10.1161/01.HYP.0000231552.10054.aa
Shafi T, Appel LJ, Miller ER, Klag MJ, Parekh RS. Changes in Serum Potassium Mediate Thiazide-Induced Diabetes. Hypertension. 2008;52(6):1022–9. DOI: 10.1161/HYPERTENSIONAHA. 108.119438. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.108.119438
Жүктөөлөр
Жарыяланды
Кандай шилтеме берүү керек
Саны (чыгарылыш)
Бөлүм
Лицензия
Copyright (c) 2024 The Author(s)
